UCB appoints new executive vice-president and general counsel

UCB has announced the appointment of Anna Richo as its new executive vice-president and general counsel.

Ms Richo will take up her new role on November 1st and is also set to become a member of the company's executive committee, having joined UCB from fellow pharmaceutical firm Amgen.

Since 2008, she served as senior vice-president and chief compliance officer at Amgen, while she also spent 12 years with Baxter earlier in her career, fulfilling a series of legal positions.

She has been hired as the successor to Bob Trainor, who will retire from UCB at the end of the year.

Roch Doliveux, chief executive officer of UCB, said: "I am very happy to welcome Anna's wealth of legal and leadership qualities, which will be a great natural fit with the global teams Bob has led."

This comes after the firm announced last week that its executive vice-president Professor Ismail Kola has been awarded a visiting professorship at Oxford Medical School.